These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8804229)
21. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170 [TBL] [Abstract][Full Text] [Related]
22. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas. Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678 [TBL] [Abstract][Full Text] [Related]
23. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas. Chew SL; Lavender P; Jain A; Weber A; Ross RJ; Wass JA; Besser GM; Clark AJ Clin Endocrinol (Oxf); 1995 Jan; 42(1):17-21. PubMed ID: 7889627 [TBL] [Abstract][Full Text] [Related]
24. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Brauch H; Kishida T; Glavac D; Chen F; Pausch F; Höfler H; Latif F; Lerman MI; Zbar B; Neumann HP Hum Genet; 1995 May; 95(5):551-6. PubMed ID: 7759077 [TBL] [Abstract][Full Text] [Related]
26. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382 [TBL] [Abstract][Full Text] [Related]
27. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1. Opocher G; Conton P; Schiavi F; Macino B; Mantero F Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705 [TBL] [Abstract][Full Text] [Related]
28. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas. Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279 [TBL] [Abstract][Full Text] [Related]
29. New insights into the genetics of familial chromaffin cell tumors. Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538 [TBL] [Abstract][Full Text] [Related]
30. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256 [TBL] [Abstract][Full Text] [Related]
31. Clinical, Biochemical, Tumoural and Mutation Profile of VHL- and MEN2A-Associated Pheochromocytoma: A Comparative Study. Dhanda M; Agarwal A; Mandal K; Gupta S; Sabaretnam M; Chand G; Mishra A; Agarwal G; Mishra SK World J Surg; 2022 Mar; 46(3):591-599. PubMed ID: 34859295 [TBL] [Abstract][Full Text] [Related]
32. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493 [TBL] [Abstract][Full Text] [Related]
33. Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease. Frenzel S; Apel TW; Heidemann PH; Zerres K; Neumann HP; Dörr HG Eur J Pediatr; 2001 Jul; 160(7):421-4. PubMed ID: 11475579 [TBL] [Abstract][Full Text] [Related]
34. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462 [TBL] [Abstract][Full Text] [Related]
35. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx. Gimm O Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706 [TBL] [Abstract][Full Text] [Related]
36. Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Rossel M; Pasini A; Chappuis S; Geneste O; Fournier L; Schuffenecker I; Takahashi M; van Grunsven LA; Urdiales JL; Rudkin BB; Lenoir GM; Billaud M Oncogene; 1997 Jan; 14(3):265-75. PubMed ID: 9018112 [TBL] [Abstract][Full Text] [Related]
37. Functioning thoracic paraganglioma: association with Von Hippel-Lindau syndrome. Bender BU; Altehöfer C; Januszewicz A; Gärtner R; Schmidt H; Hoffmann MM; Heidemann PH; Neumann HP J Clin Endocrinol Metab; 1997 Oct; 82(10):3356-60. PubMed ID: 9329368 [TBL] [Abstract][Full Text] [Related]
38. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570 [TBL] [Abstract][Full Text] [Related]
39. Von Hippel-Lindau disease: a single gene, several hereditary tumors. Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383 [TBL] [Abstract][Full Text] [Related]
40. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease. Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]